Specialty Pharmacy

05/22/2013 - 10:11am

Elan buys Austrian drug maker, stake in Dubai drug maker

Irish drug maker Elan is paying about $380 million to buy two drug makers, the company said.

05/21/2013 - 2:16pm

Report forecasts rapid rise in specialty drug spending through 2015

Spending on specialty drugs is likely to increase by 67% over the next couple of years, according to a new study by pharmacy benefit manager Express Scripts.

05/20/2013 - 1:24pm

NASP appoints Onco360 CEO to board

The National Association of Specialty Pharmacy has appointed the leader of a cancer-focused specialty pharmacy to its board of directors.

05/17/2013 - 2:18pm

Walgreens pharmacist interventions help improve compliance to newer 'triple therapy' hepatitis C treatment

More than two-thirds of patients with hepatitis C achieved sustained virologic response or cure after completing newer “triple therapy” treatment, according to a Walgreens Specialty Pharmacy study released Friday.

05/17/2013 - 11:42am

Hospira chief scientific officer returns

Hospira has reappointed its chief scientific officer after he briefly left the country earlier this year, the generic drug maker said.

05/17/2013 - 11:31am

FDA advisory committee to meet in July on opioid painkiller

A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.

05/16/2013 - 11:00am

NASP launches specialty pharmacy education web resource

The National Association of Specialty Pharmacy has launched an online resource with clinical and business-related content in more than 20 therapeutic categories, the group said Thursday.

05/15/2013 - 4:35pm

FDA approves J&J's Simponi for ulcerative colitis

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

05/15/2013 - 3:18pm

Committee advances bill to secure pharmaceutical supply chain

A federal drug track-and-trace bill has made it out of a congressional committee.

05/15/2013 - 2:23pm

FDA approves Genentech drug for lung cancer with genetic mutation

The Food and Drug Administration has approved a drug for a type of lung cancer.